Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 551–600 of 18616
Upon Mr. McCrea’s retirement, Thomas E. Long, the Partnership’s Co-Chief Executive Officer, will assume the role of sole Chief Executive Officer.
Mr. Stutz will assume the role of Interim Chief Executive Officer effective June 30, 2026.
On June 1, 2026, MillerKnoll, Inc. (the “Company”) announced that its Board of Directors (the “Board”) and Andi R. Owen, the Company’s President and Chief Executive Officer, have mutually agreed that Ms. Owen will retire from the Company effective June 30, 2026.
On May 28, 2026, Cadrenal Therapeutics, Inc. (the "Company") and Matthew K. Szot mutually agreed to his transition from the role of Chief Financial Officer, effective May 28, 2026.
Effective immediately after Mr. Szot's termination, the Company appointed Quang X. Pham, its Chief Executive Officer, as interim Chief Financial Officer and interim Principal Accounting Officer, to serve until a permanent Chief Financial Officer is appointed.
Sukhvinder Gill was appointed as Chief Financial Officer, in addition to his existing roles as Chief Operating Officer and Director of the Company
On June 3, 2026, the Company announced that Andrew Del Matto, its Chief Financial Officer, will be retiring effective upon the start of a successor.
Rejji P. Hayes has retired from his positions as CMS Energy and Consumers Energy Company (“Consumers Energy”) executive vice president and chief financial officer, effective June 3, 2026.
Srikanth (Sri) Maddipati, 43, has been appointed to succeed Hayes as CMS Energy and Consumers Energy executive vice president and chief financial officer, effective June 3, 2026.
Lyron Bentovim notified the Board of his resignation as the Chairperson and a member of the Board and all committees of the Board, and from his roles as President and Chief Executive Officer of the Company, in each case effective June 15, 2026.
On June 1, 2026, the Board appointed Tyler Gates as the Company’s President and Chief Executive Officer and as a director on the Board.
on June 1, 2026, the Board appointed Luke A. Hewko as Chief Financial Officer, Secretary, principal financial officer and principal accounting officer, effective upon Mr. Croal’s retirement.
On June 1, 2026, Thomas V. Croal notified GEN Restaurant Group, Inc. (the “Company”) of his decision to retire from his position as Chief Financial Officer, Secretary, principal financial officer and principal accounting officer of the Company, effective at the close of business on June 1, 2026.
On May 27, 2026, the Board of Directors (the “Board”) of biote Corp. (the “Company”) accepted the resignation of Bret Christensen, the Company’s Chief Executive Officer, from his position as Chief Executive Officer of BioTE Medical, LLC (“BioTE”), effective as of June 8, 2026.
Concurrently, the Board appointed Robert Peterson, current Chief Financial Officer and Chief Business Officer of BioTE, as Interim Chief Executive Officer of BioTE to fill the vacancy created by Mr. Christensen’s resignation, and as a director of the Board, each effective June 8, 2026 (the “Effective Date”).
On June 1, 2026, VisionWave IL Ltd. (“VisionWave IL”), a wholly-owned subsidiary of VisionWave Holdings, Inc. (the “Company”), entered into an Employment Agreement with Mr. Einav Eliraz pursuant to which Mr. Eliraz was appointed Chief Financial Officer (“CFO”) of VisionWave IL, effective June 1, 2026.
Kevin Beth, who departed the Company on May 27, 2026.
appointed Todd Heeter to serve as interim Chief Financial Officer and Treasurer of the Company, effective May 28, 2026
the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.
Cycurion, Inc. (the “Company”) announced that Alvin McCoy III, the Company’s Chief Financial Officer, will step down from his position effective May 31, 2026.
David S. Schulz served as the Company’s Executive Vice President and Chief Financial Officer through February 16, 2026, and continued as Executive Vice President and special advisor to the CEO until his retirement from the Company effective May 31, 2026.
Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.
On June 2, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Ardent Health, Inc. (the “Company”) appointed Dave Caspers, who previously served as the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer and as a member of the Board.
On May 27, 2026, the Board appointed Julie Knecht to become senior vice president and Chief Financial Officer (Chief Accounting Officer) of Texas Instruments Incorporated (the “Company”) effective August 1, 2026.
Ms. Knecht will succeed Rafael Lizardi, who will retire after 25 years with the Company.
Chief Financial Officer Ling Hai, age 56, the Company’s current President, Asia Pacific, Europe, Middle East and Africa, will be appointed to succeed Mr. Mehra as Chief Financial Officer of the Company.
On May 27, 2026, the Company appointed Richard Dirkson as Senior Vice President, Corporate Controller (principal accounting officer) of the Company, effective May 28, 2026.
On May 27, 2026, Tina Beskid, Cornerstone Building Brands, Inc.’s (the “Company”) Senior Vice President, Chief Accounting Officer (principal accounting officer) departed the Company.
Bernard Skaggs was terminated as the Chief Financial Officer of Picard Medical, Inc. (the “Company”), effective immediately.
In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.
On June 1, 2026, The Trade Desk, Inc. (the “Company”) announced the appointment of Nate Olmstead, age 54, as the Company’s chief financial officer.
On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the “Start Date”), to replace Mr. Green in those roles.
On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.
on May 28, 2026, the Board appointed Aaron Howald, who currently serves as Vice President, Investor Relations and Business Development, to succeed Mr. Haughie as Chief Financial Officer, effective September 1, 2026.
On June 1, 2026, Verra Mobility Corporation (the “Company”) announced that the Board of Directors of the Company (the “Board”) approved the appointment of Jonathan Keyser as the Interim President and Chief Executive Officer of the Company, effective May 31, 2026.
On June 1, 2026, the Company also announced that David Roberts would no longer serve as the Company’s President and Chief Executive Officer, effective May 31, 2026.
On May 31, 2026, the board of directors of the Company appointed Aaron Johnson, the Company’s Vice President, Finance and Accounting, as interim CFO and as the Company’s principal financial and accounting officer, succeeding Mr. Olmstead in these positions effective as of July 9, 2026, on an interim basis until the Company appoints a successor.
On May 26, 2026, Nate Olmstead notified Penguin Solutions, Inc. (the “Company”) of his decision to resign as the Company’s Senior Vice President and Chief Financial Officer (“CFO”), effective as of July 8, 2026, to pursue another opportunity in a different industry.
On May 29, 2026, Chad Chevalier, Interim Chief Financial Officer of ContextLogic Holdings Inc. (the “Company”), provided notice of his intention to resign from the Company, effective June 1, 2026.
Valmont Industries Inc. previously reported the appointment of John Schwietz as Valmont’s Executive Vice President and Chief Financial Officer and Corporate Secretary, effective April 8, 2026, to succeed Thomas Liguori.
Valmont Industries Inc. previously reported the appointment of John Schwietz as Valmont’s Executive Vice President and Chief Financial Officer and Corporate Secretary, effective April 8, 2026, to succeed Thomas Liguori.
On May 4, 2026, Mr. Dell’Osso was appointed President and Chief Executive Officer of the Company effective as of May 28, 2026.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers In connection with Dr. Joshua Ofman’s appointment as the Chief Executive Officer of GRAIL, Inc. (the “Company”), on June 1, 2026, the Company’s board of directors (the “Board”) approved an amended and restated offer letter (the “Amended Offer Letter”) and authorized and directed the Company to enter into such Amended Offer Letter with Dr. Ofman, with the Amended Offer Letter effective as of June 1, 2026 (the “Effective Date”).
On May 28, 2026, the Federal Home Loan Bank of Pittsburgh (Bank) received notice from Edward V. Weller, Chief Financial Officer, of his intent to retire from the Bank on or about October 20, 2026.
On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.
it has named Matthew D. Mullet as Chief Executive Officer of the Company effective June 1, 2026
Joe Adams, who retired as CEO of the Company on May 31, 2026
On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.
On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.
Effective May 26, 2026, Kenneth Brimmer resigned from his positions as a member of the Board of Directors and Chief Financial Officer of BT Brands, Inc.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.